Tim Lugo, partner, joined William Blair in 2005 and focuses on the therapeutics space. Mr. Lugo is the co-head of therapeutics and biotechnology research at William Blair. Before joining William Blair, he worked at Pacific Growth Equities as a junior analyst on a number of specialty pharmaceutical companies. Mr. Lugo was named No. 1 stock picker and No. 3 earnings estimator in the 2016 Thomson Reuters Analyst Awards for his coverage of biotechnology. Mr. Lugo has a BA in molecular and cellular biology (with an emphasis in genetics) and a BA in economics, both from the University of California, Berkeley.